Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE: 300255)

China flag China · Delayed Price · Currency is CNY
20.31
+0.49 (2.47%)
Dec 27, 2024, 3:04 PM CST
56.11%
Market Cap 18.27B
Revenue (ttm) 1.05B
Net Income (ttm) -844.59M
Shares Out 919.06M
EPS (ttm) -1.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,854,418
Open 19.15
Previous Close 19.82
Day's Range 19.15 - 20.80
52-Week Range 7.56 - 25.88
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Apr 28, 2025

About Hebei Changshan Biochemical Pharmaceutical

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. It offers crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadri heparin calcium API, nandroparin calcium injection, and dalteparin ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 1,410
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300255
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.